Acer Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Acer Therapeutics generated cash of -$30,251,898, which is less than the previous year. Cash used in financing activities reached the amount of $20,041,524 last year. Net change in cash is therefore -$10,381,544.
Cash Flow
| 2013 | -6.12M | 740.77K | 28.43M |
|---|---|---|---|
| 2014 | -14.19M | -190.85K | 648.17K |
| 2015 | -10.51M | -92.33K | 13.28M |
| 2016 | -9.20M | -1.22K | 65.42K |
| 2017 | -14.09M | 967.28K | 26.93M |
| 2018 | -16.58M | -95.62K | 42.71K |
| 2019 | -29.50M | -178.96K | 92 |
| 2020 | -17.02M | -10.90K | 10.72M |
| 2021 | -134.90K | -54.94K | 7.13K |
| 2022 | -30.25M | -171.17K | 20.04M |
ACER Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 12.71M | 5.76M | 12.07M | 41.67M | 15.64M | 1.83M | 12.58M | 9.90M | 23.64M | 592.00K |
Operating activities | ||||||||||
Net income | -26.23M | -15.37M | -22.88M | -29.41M | -21.28M | -14.19M | -7.98M | -12.01M | -15.05M | -16.65M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 66.03K | 70.91K | 70.81K | 58.28K | 27.74K | 3.99K | 238.12K | 351.40K | 387.77K | 335.59K |
Stock-based compensation expense | 1.84M | 2.28M | 2.22M | 2.61M | 1.31M | 418.09K | 63 | 39 | 0 | 1.19M |
| Deferred income tax benefit | 1.84M | 2.28M | 2.22M | 2.61M | 1.31M | 418.09K | 63 | 39 | 0 | 1.19M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | -1.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.40M | -266.37K | 1.11M | -472.73K | 937.95K | -287.53K | -361.89K | 37.35K | 6.33K | 147.92K |
Cash generated by operating activities | -30.25M | -134.90K | -17.02M | -29.50M | -16.58M | -14.09M | -9.20M | -10.51M | -14.19M | -6.12M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -171.17K | -54.94K | -10.90K | -178.96K | -95.62K | -62.84K | -1.22K | -92.33K | -190.85K | -259.22K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 1.03M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -171.17K | -54.94K | -10.90K | -178.96K | -95.62K | 967.28K | -1.22K | -92.33K | -190.85K | 740.77K |
Financing activities | ||||||||||
Common Stock Issued | 8.90M | 0 | 10.15M | 0 | 0 | 21.50M | 276.91K | 13.28M | 648.17K | 28.48M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.02K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | -186.70K | 0 | 0 | -550K |
Cash used in financing activities | 20.04M | 7.13K | 10.72M | 92 | 42.71K | 26.93M | 65.42K | 13.28M | 648.17K | 28.43M |
Net Change In Cash | -10.38M | 6.94M | -6.31M | -29.59M | 26.02M | 13.81M | -9.13M | 2.67M | -13.73M | 23.05M |
Cash at end of period | 2.32M | 12.71M | 5.76M | 12.07M | 41.67M | 15.64M | 3.44M | 12.58M | 9.90M | 23.64M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |